fbpx

GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

MindMatters White Logo

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Subscribe to MindMatters

What You Should Know About Clinical Trials for Brain Tumors

Researchers looking in microscope in laboratory depicting clinical trials.

Sponsored Content:
This content is
not an endorsement from the ABTA. 

Sponsored by GT Medical Technologies

Researchers looking in microscope in laboratory depicting clinical trials.

Advancements like GammaTile® Therapy are made possible by patients like you.

Over the last decade, there have only been a few medical device innovations for patients with brain tumors. Advancements like GammaTile Therapy and tumor treating fields (TTFields) have been made possible by patients who volunteer to participate in clinical trial research.   

GammaTile Therapy, also known as Surgically Targeted Radiation Therapy (STaRT), is FDA-cleared for patients with newly diagnosed malignant and recurrent brain tumors.

Clinical trials provide access to advanced treatment options.

Unfortunately, the “go-to” standard of care isn’t always the most advanced treatment optionClinical trials help provide opportunities for patients to gain access to innovative treatment options that aren’t yet mainstream or available to the public. Often conducted by leading healthcare facilities and their physicians, clinical trials can advance medical research and lead to improved outcomes for patients with brain tumors.

Participation in clinical trials pays it forward—it’s a contribution to medicine and patients like you.

These clinical studies are vital for a deeper understanding of brain tumors and for evaluating how newer surgery methods and treatments may be safer and more effective than the current treatments. 

It is important to understand that clinical trials are experimental, testing new ways to detect, treat, and prevent brain tumors. Some clinical trials further evaluate treatments that have already been FDA-approved or FDA-cleared to gather additional information on their effectiveness alone or in combination with other treatments. Through this scientific research, new therapies will be tested with the ultimate goal of finding a cure for brain tumors. 

When you participate in a clinical trial, you’re contributing to research and advancing treatment for others. 

Find out if a clinical trial may be right for you.

You can ask your medical team if they know of any clinical trials that may be right for you. Each clinical trial has specific eligibility criteria for participation. You can also do your own research at ClinicalTrials.gov. View currently recruiting GammaTile Therapy clinical trials here. 

Picture of Jessie Schlacks

Jessie Schlacks

Jessie is Managing Editor of the bi-monthly e-newsletter MindMatters. Submit story ideas or questions to jschlacks@abta.org.


 

Advancing Brain Tumor Research and Support

Thanks to the generous support of donors like you, the American Brain Tumor Association has invested over $35 million in life-changing brain tumor research, helping pave the way for breakthroughs like the FDA approval of vorasidenib, a groundbreaking treatment for low-grade glioma. Through our Meet Hope Head On campaign, we continue funding critical research and providing free resources for patients and caregivers—bringing hope and advancing care for the brain tumor community.

Share This Content:

Share:

More Posts

Upcoming Events

Educational Resources

Always free for patients & caregivers

Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor

Double Your Impact for Brain Tumor Families

Donate now and your gift will be matched thanks to the Will Hicks Charitable Association.